Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements
Manuscript Objectives: Review the challenges and opportunities for SC delivery of high dose/volume biologics Consider…...
Subcutaneous
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
Manuscript Objectives: Explore a potential biopharmaceutics classification system that could guide the development of a…...
Accelerating the Development of Novel Technologies and Tools for the SC Delivery of Biotherapeutics
Key Objectives: Provide overview of the mission and objectives of SC Consortium to advance the…...
© 2024 Subcutaneous Drug Development & Delivery Consortium
English